BsUFA III Talks Begin With Regulatory Science Disagreement

Anti-recessionary injection (vaccination) by hundred dollar denomination close up on a black background
Negotiations to extend BsUFA another five years began in March • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products